Overview

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the safety and efficacy of G238 for the treatment of otomycosis
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Salvat
Treatments:
Clotrimazole
Miconazole
Criteria
Inclusion Criteria:

- 18 years or older.

- Clinical diagnosis of otomycosis where topical treatment is indicated.

Exclusion Criteria:

- Other ear diseases.